Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
2.800
+0.060 (2.19%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Altimmune Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 532 | 394 | 513 | 604 | 808 | 363 | |
| Market Cap Growth | 66.08% | -23.16% | -15.16% | -25.23% | 122.62% | -12.91% | |
| Enterprise Value | 294 | 199 | 375 | 464 | 608 | 165 | |
| Last Close Price | 2.74 | 3.61 | 7.21 | 11.25 | 16.45 | 9.16 | |
| PS Ratio | 12978.20 | 9610.97 | 25640.43 | 1418.90 | -11888.90 | 82.35 | |
| PB Ratio | 1.35 | 1.75 | 4.15 | 3.11 | 4.36 | 1.82 | |
| P/TBV Ratio | 2.37 | 1.75 | 4.15 | 3.11 | 4.68 | 1.95 | |
| EV/Sales Ratio | 7178.98 | 4858.01 | 18760.08 | 1090.28 | - | 37.39 | |
| Debt / Equity Ratio | 0.16 | 0.16 | 0.01 | 0.00 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.06 | -1.06 | -1.05 | -1.02 | -0.99 | -0.95 | |
| Net Debt / EBITDA Ratio | 2.52 | 2.52 | 1.26 | 2.37 | 2.11 | 2.24 | |
| Net Debt / FCF Ratio | 3.52 | 3.52 | 1.63 | 2.60 | 2.93 | 2.09 | |
| Asset Turnover | 0 | 0 | 0 | 0.00 | - | 0.02 | |
| Quick Ratio | 18.35 | 18.35 | 12.90 | 16.69 | 10.99 | 10.73 | |
| Current Ratio | 18.55 | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 | |
| Return on Equity (ROE) | -50.57% | -50.57% | -59.86% | -46.63% | -44.07% | -45.69% | |
| Return on Assets (ROA) | -28.17% | -28.17% | -36.85% | -25.00% | -25.73% | -22.86% | |
| Return on Capital Employed (ROCE) | -35.70% | -35.70% | -80.10% | -42.10% | -46.20% | -42.30% | |
| Earnings Yield | -16.56% | -22.36% | -18.54% | -14.63% | -10.48% | -26.74% | |
| FCF Yield | -12.69% | -17.14% | -15.57% | -12.55% | -7.76% | -24.88% | |
| Buyback Yield / Dilution | -24.08% | -24.08% | -33.35% | -13.47% | -13.67% | -61.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.